Demographic and practice characteristics | |
Female gender | 157 (72.4) |
Specialty | |
Family physician | 132 (60.8) |
Obstetrician-gynecologist | 85 (39.2) |
Practice setting | |
Academic | 43 (19.8) |
Private practice | 122 (56.2) |
Public health | 47 (21.7) |
Trains residents or fellows | 141 (65.0) |
≥10 years since residency | 134 (61.8) |
≥10 LNG-IUSs inserted/year | 96 (44.2) |
Knowledge | |
General, answered correctly | |
LNG-IUS failure rate | 177 (81.6) |
LNG-IUS FDA-approved duration of use | 198 (91.2) |
Perfect score on 2 general knowledge items | 163 (75.1) |
Complications, answered correctly | |
Infertility after removal | 206 (94.9) |
Increased risk for PID ≥20 days after insertion | 198 (91.2) |
Increased risk for PID <20 days after insertion | 125 (57.6) |
Increased risk of STI | 195 (89.9) |
Increased risk of ectopic pregnancy | 123 (56.7) |
Complications score, mean number answered correctly out of 5 (SD)* | 3.9 (0.93) |
Attitudes | |
Factors that negatively influence decision to recommend LNG-IUS, answered yes | |
Increased risk of PID/STIs/infertility | 48 (22.1) |
Cramping/pain side effect | 25 (11.5) |
Irregular bleeding side effect | 69 (31.8) |
Medical liability | 4 (1.8) |
Cost | 47 (21.7) |
Practice | |
Routinely recommend LNG-IUS for the following patients, answered yes | |
Nulliparous women | 121 (55.8) |
Women with a history of STIs/PID | 82 (37.8) |
Women with a history of ectopic pregnancy | 81 (37.3) |
Women <20 years old | 80 (36.9) |
Data are n (%).
↵* Complications score is calculated from number of correct answers on the 5 questions listed.
PID, pelvic inflammatory disease; SD, standard deviation; STI, sexually transmitted infection; FDA, US Food and Drug Administration.